Our UHN programs and services are among the most advanced in the world. We have grouped our physicians, staff, services and resources into 10 medical programs to meet the needs of our patients and help us make the most of our resources.
University Health Network is a health care and medical research organization in Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international source for discovery, education and patient care.
Our 10 medical programs are spread across eight hospital sites – Princess Margaret, Toronto General, Toronto Rehab’s five sites, Toronto Western – as well as our education programs through the Michener Institute of Education at UHN. Learn more about the services, programs and amenities offered at each location.
Maps & Directions
Find out how to get to and around our nine locations — floor plans, parking, public transit, accessibility services, and shuttle information.
Ways You Can Help
Being touched by illness affects us in different ways. Many people want to give back to the community and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one of our experts for an interview. It’s also the place to find UHN media policies and catch up on our news stories, videos, media releases, podcasts and more.
The Krembil research community will welcome its newest member this week: Dr. Michael Reber, a neurobiologist with expertise in computational biology and mathematics.
Dr. Reber's research program examines the brain's visual network, which consists of interconnected "webs" of cells that transmit and process visual information from the eyes. He uses a combination of experimental and mathematical models to reveal how the development and organization of the visual network is directed by particular molecules in the brain and eye.
Many of his studies have focused on a family of molecules known as ephrins. He and his colleagues have shown that gradients of ephrins direct the development of the visual network in the superior colliculus, a region in the middle of the brain.
They have also found that disturbing ephrin gradients can lead to a duplication of some parts of the visual network, which produces symptoms similar to those observed in attention deficit hyperactivity disorder.
Upon his arrival in Toronto, where he will be based at the Donald K. Johnson Eye Institute, Dr. Reber will continue studying the brain's visual network. He will also begin examining how diseases of the retina and optic nerve affect its development. For example, he and Dr. Jeremy Sivak are planning to investigate how glaucoma, a leading cause of irreversible blindness, affects the visual network. Through another exciting project, he will validate the use of silk nanofibers to promote survival and repair of injured brain cells.
Before joining Krembil, Dr. Reber was an Associate Professor at the Institute of Cellular & Integrative Neurosciences in Strasbourg, France. He completed his PhD at Paris Diderot University in France and his postdoctoral fellowship at the Salk Institute in California.
Dr. Reber's recruitment was made possible by the generous support of Donald K. and Anna Johnson through the Toronto General & Western Hospital Foundation.